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OBJECTIVE: The purpose of this article is to present the potentials and limits of contrast-enhanced ultrasono-
graphy (CEUS) in the characterization of pancreatic tumors, usually hypoechoic or cystic at B-mode ultrasound. 
CONCLUSION: As regards hypoechoic lesions at B-mode ultrasound, CEUS often can distinguish among adeno-
carcinoma, islet cell tumor and serous microcystic adenoma. As regards cystic lesions, CEUS in most cases doesn’t 
add significative diagnostic information; therefore CT, MR or endoscopic US are almost always necessary for their 
proper characterization.  
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Introduction 
Imaging of pancreatic tumors takes advantage of 
various techniques, such as B-mode ultrasound (US), 
computed tomography (CT) and magnetic resonance 
(MR). 
B-mode US allows the detection of focal lesions, 
even small ones about 1 cm in diameter, that usually 
are hypoechoic or cystic. However, within hypoechoic 
lesions B-mode US is not able to differentiate adeno-
carcinoma (the most frequent tumor), islet cell tumor 
or other more rare diseases (microcystic adenoma; 
focal pancreatitis). Similarly, within cystic lesions 
B-mode US is not often able to differentiate pseudo-
cyst, serous cystadenoma, mucinous cystic neoplasm 
(MCN), intraductal papillary mucinous tumor (IPMT).  
The aim of our pictorial essay is to illustrate the 
potentials and limits of contrast-enhanced ultrasono-
graphy (CEUS) in the characterization of focal pancre-
atic lesions. 
CEUS technique 
CEUS, by using a blood pool contrast agent, can 
provide dynamic information concerning macro- and 
micro-circulation of focal lesions and of normal pa-
renchyma [1]. In our experience, all CEUS examina-
tions were performed on a Technos MPX ultrasound 
system (Esaote Biomedica, Genova, Italy), with har-
monic microbubble specific imaging (CnTI: Contrast 
Tuned Imaging) with low acoustic ultrasound pressure 
(MI: 0,093-0,157). A 2,4 ml bolus of second generation 
contrast agent (Sonovue, Bracco, Milano, Italy) was 
injected intravenously, followed by a 10-ml bolus of 
saline solution. 
All images were stored on the ultrasound ma-
chine as 3 clips lasting 60 seconds each; the dynamic 
observation of the contrastographic phases (early arte-
rial, arterial, pancreatic, portal and late phases) was 
possible by maintaining the same scanning frame rate 
of the B-mode examination.  
CEUS appearance   
1) HYPOECHOIC TUMORS AT B-MODE US 
Focal lesions that are hypoechoic at B-mode US 
can be classified at CEUS as hypoechoic, isoechoic, 
hyperechoic, according to their enhancement com-
pared to that of the surrounding parenchyma. 
a) Ductal adenocarcinoma is usually hypoechoic 
(absent or poor enhancement compared to normal 
pancreatic parenchyma), because of its scanty vascu-
larization [2] (Fig. 1). In particular, tumors in which the 
size of the hypoechoic area is unchanged on CEUS 
have clear margins with no infiltration or inflamma-
tion; tumors in which the size of the hypoechoic area is 
reduced on CEUS have blurred margins with infiltra-
tion of cancerous cells and inflammation. CEUS may 
be a tool for evaluating pathologic changes of pancre-
atic cancer and may provide useful information in the 
pre-treatment phase [2]. Int. J. Med. Sci. 2008, 5 
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Ductal adenocarcinoma is rarely isoechoic (en-
hancement similar to normal pancreatic parenchyma); 
this pattern is due to a moderate vascularization (Fig. 
2) occurring in some histotypes (anaplastic carcinoma 
and acinar cell carcinoma) [3]. The isoechoic pattern is 
often observed in focal pancreatitis too [4]: therefore, 
CEUS is not always able to accurately differentiate 
adenocarcinoma from focal pancreatitis, as well as CT 
and MR [5].  
Ozawa et al [6] studied 25 pancreatic mass lesions 
with CEUS and found out that 5/20 adenocarcinoma 
didn’t show any enhancement in the arterial phase and 
among these only 5 showed a peripheral enhancement 
in the late phase; on the contrary, all inflammatory 
lesions showed a mild enhancement. The amount of 
necrosis, inflammation and fibrosis is the 
anatomo-pathological substrate responsible for dif-
ferent pattern of vascularization and therefore prob-
lems of differential diagnosis [7]. Whereas edema and 
inflammation requires vascular supply, when fibrosis 
increases during chronic pancreatitis vascular supply 
diminishes and subsequently contrast enhancement is 
less vivid. For example, in autoimmune pancreatitis 
the enhancement is significant in the early phase, 
though inhomogeneous, due to lymphocytes infiltrate 
and perivessel fibrosis.  
D’Onofrio et al [4] studied 173 patients affected 
by pancreatic masses: they could reach a correct diag-
nosis of focal pancreatitis in 35 cases (19 alco-
hol-related, 15 autoimmune, 1 genetic) with a sensibil-
ity of 88.8%, specificity of 97.8%, positive predictive 
value of 91.2%, negative predictive value of 97.1% and 
accuracy of 96%. 
b) Islet cell tumors- functioning or nonfunction-
ing – are usually hyperechoic in the arterial phase 
(enhancement superior to normal pancreatic paren-
chyma) because of their rich vascularization [8]; after 
the enhancement a rapid washout of the lesion is ap-
preciable, resulting in a slightly hypoechoic appear-
ance during the venous phase [8]. Sometimes, en-
hancement is more important in the portal phase (Fig. 
3), similarly to what has been reported for dynamic 
studies perfo rmed with CT [9]. In addition, in h uge 
nonfunctioning islet cell tumors, enhancement may be 
heterogeneous due to necrosis or cystic degeneration 
[8]. 
A similar CEUS pattern can also be observed in 
hypervascular metastases (from renal cell carcinoma 
and melanoma) [3]. 
c) Serous microcystic adenomas (SMAs) some-
times show at B-mode US a hypoechoic 
“solid-appearing” pattern, due to submacroscopic size 
of the cysts [10] (Fig. 4A); these tumors can be properly 
characterized by CEUS that demonstrates the typical 
honeycomb pattern (Fig. 4B), as well as by MR [11] 
(Figs. 4C and D). 
2) CYSTIC TUMORS AT B-MODE US 
Recently, a simple imaging-based classification of 
pancreatic cystic lesions into 4 types has been pro-
posed: microcystic, unilocular, macrocystic, cystic with 
a solid component [12]. 
a) B-mode US can characterize a SMA when it 
demonstrates the typical honeycomb appearance 
[10,12]; CEUS, by depicting septa enhancement and the 
absence of papillary projections, allows a better diag-
nostic confidence (Fig. 5). In case of small nonsurgical 
lesions, CEUS doesn’t need a further diagnostic step 
with CT and/or MR. 
b) Unilocular single cyst (without internal septa, 
solid component, parietal or central calcifications) at 
B-mode US can be referred to pseudocyst, oligocystic 
serous cystadenoma, MCN, IPMT (branch-duct type) 
[12]; CEUS doesn’t give any additional diagnostic in-
formation (Figs. 6A and B): in particular it is not able to 
find out communication with the pancreatic duct that 
can be demonstrated by MR cholangiopancreatogra-
phy or CT, especially with curved reformatted images 
(Figs. 6C and D), in IPMTs [13].  
Likewise, when two or more unilocular cysts are 
present, the differential diagnosis – restricted between 
pseudocysts and IPMTs [12] - cannot be made by 
CEUS and the resort to CT or MR is mandatory (Fig. 7).   
c) Macrocystic lesions include multilocular cysts 
with fewer compartments than SMAs; besides, the 
compartments (> 2 cm) are larger [12]; this category 
includes MCN and IPMT. A thick wall, thick septa and 
mural or septa calcifications are the most important 
findings associated with malignancy [12,14]. In these 
cases, although CEUS permits a better visualization of 
wall and septa [15], it does not give a significative di-
agnostic gain in comparison with B-mode US (Fig. 8). 
d) Cysts with a solid component at B-mode US 
may be either unilocular or multilocular; true cystic 
tumors (MCN and IPMT) as well as solid tumors with 
a cystic component or cystic degeneration – primary or 
metastatic – are included in this category. All tumors 
of this group are either malignant or have a high ma-
lignant potential [12]; in these cases too CEUS does not 
offer a meaningful diagnostic contribution (Fig. 9). 
CONCLUSIONS 
As regards pancreatic hypoechoic lesions at 
B-mode US, CEUS - by detecting their vascularisation - 
is a reliable imaging modality for their characteriza-
tion. Sometimes, it may conclude the diagnostic 
work-up; however, in tumors judged resectable by 
CEUS, CT and/or MR are necessary for a more accu-Int. J. Med. Sci. 2008, 5 
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rate evaluation of the local extension and metastatic 
spread, in order to confirm their resectability. 
As regards cystic lesions at B-mode US, CEUS 
may give a higher diagnostic confidence, by depicting 
better septa and mural nodules, but in most cases it 
doesn’t add significative information. Therefore, CT, 
MR or endoscopic US are almost always necessary for 
their characterization as well as for evaluation of their 
extension. Patient management depends on many 
factors (age, surgical risk, symptoms) as well as on 
imaging; in particular for small lesions (diameter ≤ 3 
cm) without a solid component, which are very often 
benign, careful radiological follow-up is preferable to 
surgery [16].  
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Figures 
 
Fig. 1.- Adenocarcinoma in a 85-year-old woman who presented with diabetes at sudden onset. A. B-mode US (transverse scan) 
shows a hypoechoic mass, located in the head of the pancreas (asterisks), 3.5 cm in diameter. Splenic vein (arrow) is visible. B. On 
CEUS the mass is hypoechoic (asterisks) compared to the surrounding parenchyma in the arterial phase. C. MDCT curved refor-
matted image depicts pancreatic duct dilatation and hypodense lesion in the head of the pancreas. 
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Fig 2.- Adenocarcinoma in a 45-year-old woman who presented with jaundice. A. B-mode US (trasverse scan) shows a hypoechoic 
mass in the head of the pancreas, 4 cm in diameter. Main pancreatic duct dilatation (arrow) is visible. B. On CEUS the mass is 
isoechoic in the arterial phase.  
 
 
 
Fig 3- Nonfunctioning islet cell tumor in an asymptomatic 80-year-old woman. A. B-mode US shows a 2-cm hypoechoic nodule 
(calipers) located in the uncinate process of the pancreas. B. On CEUS the nodule is hyperechoic (asterisks) in the portal phase. C. 
Axial CT image depicts the same nodule as hyperdense in the venous phase (arrow). 
 
 
 
Fig 4- Serous microcystic adenoma in an asymptomatic 66-year-old woman. A. B-mode US shows a hypoechoic mass (calipers) 
located in the head of the pancreas. B. On CEUS the lesion has a honeycomb appearance (asterisks), typical of serous microcystic 
adenoma. C. Axial T2-weighted MR image shows a hyperintese lesion made up of cluster of microcysts. D. Axial gadolin-
ium-enhanced fat-suppressed T1-weighted MR image depicts the honeycomb appearance with enhancement of thin septa.  Int. J. Med. Sci. 2008, 5 
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Fig 5- Serous microcystic adenoma in an asymptomatic 82-year-old woman. A. B-mode US shows a focal lesion located in the head 
of the pancreas with a honeycomb appearance. Superior mesenteric artery (arrow) is visible. B. CEUS confirms the findings of 
B-mode US, allowing a better diagnostic confidence. 
 
 
Fig 6- Benign mucinous cystic neoplasm in a 79 old-woman with history of abdominal pain. A. B-mode US shows a unilocular cyst 
3,5 cm in diameter (asterisk), located in the uncinate process of the pancreas; main pancreatic duct, not dilated (white arrow), is 
visible. B. CEUS image confirms the unilocular aspect of the cyst (asterisk), without septa or mural nodules. C and D. MDCT 
confirms on axial image (C) the unilocular aspect of the cyst (asterisk) and on MinIP image (D) demonstrates the absence of 
communication with the pancreatic duct (black arrow); dilated bile duct (white arrow) is visible. 
 
 
Fig 7- Double benign intraductal papillary mucinous tumor in an asymptomatic 72-year-old woman. A. B-mode US shows two 
simple cysts (arrows) located in the head of the pancreas. B. CEUS confirms the presence of two simple cysts without septa or mural 
nodules (arrows). C and D. MR on axial T2-weighted image (C) confirms the unilocular aspect of the cysts (arrows) and on coronal 
T2-weighted image (D) well demonstrates the communication of the greater cyst with the pancreatic duct (arrowhead). 
 
 
Fig. 8 - Benign intraductal papillary mucinous tumor in an asymptomatic 81-year-old woman. A. B-mode US shows a huge multi-
locular cyst (calipers) with compartments > 2 cm in diameter located in the head of the pancreas. B. CEUS better shows thin septa 
and absence of papillary projections in the lesion (calipers). Portal vein (arrow) is filled with contrast agent. C and D. MDCT on axial 
image (C) confirms a macrocystic lesion with thin septa; on curved reformatted image (D) the communication with the pancreatic 
duct is demonstrated.  Int. J. Med. Sci. 2008, 5 
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Fig 9- Malignant intraductal papillary mucinous tumor in a 80-year-old man who presented with obstructive jaundice. A. B-mode US 
shows a multilocular cystic lesion with mural nodules (calipers) located in the head of the pancreas. B. CEUS well depicts the 
vascularized septa and nodules in the lesion (calipers). Superior mesenteric artery (black arrow) and superior mesenteric vein (white 
arrow) are filled with contrast agent. C and D. MDCT on axial image (C) shows a multilocular lesion with a solid component; a stent 
is inserted in the common bile duct (arrow); on the curved reformatted image (D) the communication of the tumor with the pancreatic 
duct is demonstrated. 